Congressional trading
Who in Congress traded REGN?
Regeneron Pharmaceuticals, Inc. - Common Stock · classified as Health care. 16 disclosed transactions across 6 members.
16
Transactions
6
Members
4 / 12
Buys / sells
2
Filed late
Committee overlap
2 of 6 members who traded REGN sit on a committee with jurisdiction over Health care. This is a disclosed structural overlap, not evidence of wrongdoing. Nothing here asserts that any member acted on non-public information. Jurisdiction is mapped from published House and Senate committee rules — see the methodology.
Members
6 transactions- Sell2025-01-24$1,001 - $15,000(Joint)disclosed after 13dfiling
- Partial sell2024-11-29$1,001 - $15,000(Joint)disclosed after 4dfiling
- Partial sell2024-11-19$1,001 - $15,000(Joint)disclosed after 14dfiling
- Partial sell2024-10-23$1,001 - $15,000(Joint)disclosed after 13dfiling
- Partial sell2024-07-01$1,001 - $15,000(Joint)disclosed after 42dfiling
- Partial sell2024-02-08$1,001 - $15,000(Joint)disclosed after 26dfiling
3 transactions
3 transactions
2 transactionsCommittee overlap1 filed past the 45-day deadline
1 transactionCommittee overlap1 filed past the 45-day deadline- Buy2026-03-27$1,001 - $15,000disclosed after 116dfiling
1 transaction- Sell2025-04-10$1,001 - $15,000(Spouse)disclosed after 25dfiling
Where this comes from
15 transactions from House Clerk Periodic Transaction Reports and 1 from Senate eFD filings. Amounts are the statutory brackets filers report — Congress does not disclose exact values. Senate filings carry one filing date per report rather than per transaction, so “disclosed after” for a Senate row is measured to the date the whole report was filed. This page is a conflict-of-interest disclosure, not investment advice or a trading signal.